Lite Strategy (LITS) Asset Utilization Ratio (2017 - 2024)
Lite Strategy (LITS) posted Asset Utilization Ratio of 1.16 for Q2 2024, up 30.09% on a QoQ basis from 0.89 in Q1 2024, and up 202.82% year-over-year from 0.38 in Q3 2023.
Analysis
Lite Strategy (LITS) Asset Utilization Ratio (2017 - 2024) Analysis & Trends
Lite Strategy has reported Asset Utilization Ratio for 8 years, with the latest figure at 1.16 in Q2 2024.
- On a quarterly basis, Asset Utilization Ratio rose 202.82% year-over-year to 1.16 in Q2 2024; TTM through Jun 2024 was 1.16, a 202.82% increase from a year earlier, with the FY2024 full-year figure at 0.81, up 146.31% from the prior year.
- Asset Utilization Ratio was 1.16 for Q2 2024 at Lite Strategy, up from 0.89 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 1.16 in Q2 2024, with the low at 0.04 in Q1 2020.
- Average Asset Utilization Ratio over 5 years is 0.4, with a median of 0.23 recorded in 2020.
- The sharpest annual moves came in 2021 and 2022: Asset Utilization Ratio surged 508.32% in 2021, then sank 32.87% in 2022.
- Over 5 years, Asset Utilization Ratio stood at 0.22 in 2020, then retreated by 17.2% to 0.18 in 2021, then jumped by 120.7% to 0.4 in 2022, then soared by 100.95% to 0.81 in 2023, then jumped by 43.47% to 1.16 in 2024.
- The last three Asset Utilization Ratio figures came in at 1.16 (Q2 2024), 0.89 (Q1 2024), and 0.81 (Q4 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 0.40 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 0.58 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 0.47 |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 0.38 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 0.20 |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 0.90 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 0.33 |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 0.00 |
| 10 | Lite Strategy | 38.03 Mn | 30.49 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 1.16 |
| Mar 31, 2024 | 0.89 |
| Dec 31, 2023 | 0.81 |
| Sep 30, 2023 | 0.95 |
| Jun 30, 2023 | 0.38 |
| Mar 31, 2023 | 0.42 |
| Dec 31, 2022 | 0.40 |
| Sep 30, 2022 | 0.24 |
| Jun 30, 2022 | 0.22 |
| Mar 31, 2022 | 0.18 |
| Dec 31, 2021 | 0.18 |
| Sep 30, 2021 | 0.20 |
| Jun 30, 2021 | 0.19 |
| Mar 31, 2021 | 0.27 |
| Dec 31, 2020 | 0.22 |
| Sep 30, 2020 | 0.16 |
| Jun 30, 2020 | 0.19 |
| Mar 31, 2020 | 0.04 |
| Dec 31, 2019 | 0.05 |
| Sep 30, 2019 | 0.07 |